Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05868668 · ClinicalTrials.gov registry record · NA

Efficacy of Low-intensity Shockwave vs Radial Wave for Treatment of Erectile Dysfunction and Pelvic Pain

A NA study of Erectile Dysfunction and Chronic Pelvic Pain Syndrome, sponsored by The Cleveland Clinic.

Recruiting
Registry status
NA
Development phase
186
Enrollment target
1
Study location

NCT05868668: Recruiting NA study of Erectile Dysfunction and Chronic Pelvic Pain Syndrome, sponsored by The Cleveland Clinic.

NCT05868668 is a NA study of Erectile Dysfunction and Chronic Pelvic Pain Syndrome that is actively recruiting participants, run by The Cleveland Clinic. The registered enrollment target is 186 participants, below the 226-participant average among 33 other Erectile Dysfunction trials with a reported enrollment target (18% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05868668, a NA study of Erectile Dysfunction and Chronic Pelvic Pain Syndrome, is actively recruiting participants, sponsored by The Cleveland Clinic.

RECRUITING
Registry status
NA
Development phase
186 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study to perform a randomized, sham controlled analysis of the effectiveness of both fSWT and rWT in the relief of erectile dysfunction and chronic pelvic pain syndrome.

Primary Outcome

To evaluate change/minimum clinically important difference (MCID) of International Index of Erectile Function score. Score varies according to baseline ED severity, generally requiring higher value for more severe symptoms.

Interventions

  • DEVICE Focused shockwave
  • DEVICE Radial wave
  • DEVICE Sham treatment

Study Locations (1)

Ohio

  • Cleveland Clinic Foundation - Cleveland

Trial Details

FieldValue
Enrollment Target 186 participants
Start Date 2023-09-19
Est. Completion 2026-06
Phase NA
The Cleveland Clinic

688 total trials

What NCT05868668 shows while recruiting

NCT05868668 is an interventional study that assigns participants to a tested intervention. The registered 186 participants enrollment target is mid-sized for trials with a published cap, below the 226-participant average among 33 other Erectile Dysfunction trials with a reported enrollment target (18% lower).

The record links to 7 conditions, with Erectile Dysfunction appearing as the primary indexed condition, and to 3 interventions - of which Focused shockwave is the first listed.

NCT05868668 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT05868668 about?

NCT05868668 is a clinical study titled "Efficacy of Low-intensity Shockwave vs Radial Wave for Treatment of Erectile Dysfunction and Pelvic Pain". The purpose of this study to perform a randomized, sham controlled analysis of the effectiveness of both fSWT and rWT in the relief of erectile dysfunction and chronic pelvic pain syndrome.

What is the current status of trial NCT05868668?

This trial is currently recruiting. It is a NA study. The enrollment target is 186 participants. The study started on 2023-09-19. Estimated completion is 2026-06.

What conditions does trial NCT05868668 study?

This clinical trial studies the following conditions: Erectile Dysfunction, Chronic Pelvic Pain Syndrome, Erectile Dysfunction Following Radical Prostatectomy, Chronic Prostatitis, Erectile Dysfunction Due to Arterial Insufficiency.

What interventions are being tested in trial NCT05868668?

The interventions under investigation include: Focused shockwave (DEVICE), Radial wave (DEVICE), Sham treatment (DEVICE).

Who is sponsoring clinical trial NCT05868668?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05868668 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Erectile Dysfunction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05868668's enrollment target sits among peer trials

186 12th of 33 higher than 22 of 33 other Erectile Dysfunction trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Erectile Dysfunction trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03567889 · 186 participants · Phase 3

    Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients

  • NCT05281471 · 186 participants · Phase 3

    Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)

  • NCT05405595 · 186 participants · Phase 1

    ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors

  • NCT05762107 · 186 participants · Phase 2

    A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05868668, the US trial registry maintained by the National Library of Medicine. NCT05868668 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.